HOME >> BIOLOGY >> NEWS
Risk of common vaginal infection linked to preterm birth appears higher for blacks

BOSTON, Aug. 11 Risk of a common vaginal infection linked to preterm birth appears to escalate when even one partner is African-American, according to a University of Pittsburgh School of Medicine study presented today at the 34th annual meeting of the Infectious Diseases Society for Obstetrics and Gynecology in Boston.

When a pregnant woman has bacterial vaginosis, her risk of preterm birth goes up, said Hyagriv Simhan, M.D., M.S.C.R., assistant professor of obstetrics, gynecology and reproductive sciences at the University of Pittsburgh School of Medicine. And now we can say that gauging risk for bacterial vaginosis is not as simple as just looking at the woman. We also should consider her partner.

Bacterial vaginosis (BV) is a common gynecological infection that affects up to 50 percent of women in some populations. BV is characterized by an increase in vaginal alkalinity and an overgrowth of abnormal bacteria. Among the infections more prominent symptoms is a milky, foul-smelling discharge.

For years, clinicians have thought of BV infection as a minor problem, but in addition to increasing the risk for preterm birth, other studies have shown that women who have BV also are more likely to get herpes and other sexually transmitted diseases, including HIV, said Dr. Simhan, a maternal-fetal medicine specialist at the Magee-Womens Hospital of the University of Pittsburgh Medical Center.

For this observational study, Dr. Simhan and his colleagues considered 325 women who were in their first trimester of pregnancy. Among these women, 129 (39.7 percent) were white female/white male partnerships, 35 (10.8 percent) were white female/black male couples, 12 (3.7 percent) were black female/white male couples, and 149 (45.9 percent) were black female/black male partnerships.

Generally, BV was less common among white women compared to black women in the group. But notably, partner race also showed an influence on BV risk,
'"/>

Contact: Michele D. Baum
BaumMD@upmc.edu
412-647-3555
University of Pittsburgh Schools of the Health Sciences
11-Aug-2007


Page: 1 2

Related biology news :

1. Features of replication suggest viruses have common themes, vulnerabilities
2. New gene mutation identified in common type of dementia
3. Study identifies a common genetic risk factor for colorectal and prostate cancer
4. Researchers pit novel version of common virus against cancer
5. Gene responsible for common hearing loss identified for first time
6. OSA symptoms more common among African-American women than Caucasians
7. Sensitivity to diverse range of chemotherapeutic drugs linked to common pathway
8. Largest ever study of genetics of common diseases published today
9. First confirmed common genetic risk factors for breast cancer
10. Scripps research study shows humans and plants share common regulatory pathway
11. Salamanders suffer delayed effects of common herbicide

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:10/17/2019)... ... 15, 2019 , ... Modality Solutions, a biopharmaceutical ... on the Houston Business Journal’s Fast 100 list. Modality Solutions ranked No. 91 ... in Houston, Modality Solutions is a biopharmaceutical cold chain engineering firm with regulatory ...
(Date:10/11/2019)... ... October 11, 2019 , ... ... surgeon, oncologist, and researcher Dr. Pavel Tyan has been appointed Therapeutic Lead for ... the organization, further enhancing the already strong scientific and delivery credentials previously offered ...
(Date:10/8/2019)... ... October 08, 2019 , ... ... that make it easier than ever for businesses and organizations to use their ... App enables organizations to count down to or count up from date-related milestones, ...
Breaking Biology News(10 mins):
(Date:10/3/2019)... ... October 01, 2019 , ... Today Cereset®, the ... the midway point of its randomized research trial for individuals with persisting symptoms ... the efficacy of a non-invasive technology which compares tones delivered to a subject’s ...
(Date:10/3/2019)... ... October 02, 2019 , ... ... is pleased to announce that it has moved into a new, 5000 sqft, ... instruments, the new facility demonstrates the company's continuous commitment to quality research and ...
(Date:9/24/2019)... Mass. (PRWEB) , ... September ... ... global provider of advanced delivery technologies, development, and manufacturing solutions for drugs, ... NERV), a clinical-stage biopharmaceutical company focused on the development of therapies to ...
(Date:9/17/2019)... ... September 17, 2019 , ... Catalent, a ... and Clinical Supplies Management, Asia Pacific (APAC) will present at the upcoming 3rd ... Sept. 25-26, 2019. , On Thursday, Sept. 26, at 10:10 a.m., Ms. Delaney ...
Breaking Biology Technology:
Cached News: